ARCHIVES

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 17 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Organ Systems Meeting Canceled

November 19, 1982

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

NCI Rethinks Cancer Center Grants

March 14, 2014

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

April 26, 1996